Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1091220060Completed
Open-label trial of oreongsan in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Kori. Primary endpoint: prevention effect of postoperative nausea and vomiting. Started Jun 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1091220060.